BerandaPTCT • NASDAQ
add
PTC Therapeutics, Inc.
Tutup sebelumnya
$40,76
Rentang tahun
$28,72 - $58,38
Kapitalisasi pasar
3,23Â M USD
Volume Rata-Rata
1,42Â jt
Rasio P/E
6,27
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 213,17Â jt | -30,58% |
Biaya operasional | 87,99Â jt | -42,66% |
Laba bersih | -65,89Â jt | 57,71% |
Margin laba bersih | -30,91 | 39,08% |
Penghasilan per saham | -0,34 | -17,15% |
EBITDA | -9,11Â jt | -110,86% |
Tarif pajak efektif | 30,43% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,15Â M | 30,66% |
Total aset | 1,71Â M | -10,06% |
Total liabilitas | 2,80Â M | 3,27% |
Total ekuitas | -1,10 M | — |
Saham yang beredar | 78,87 jt | — |
Harga terhadap nilai buku | -2,88 | — |
Tingkat pengembalian aset | -2,24% | — |
Tingkat pengembalian modal | -2,83% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -65,89Â jt | 57,71% |
Kas dari operasi | -30,00Â jt | 70,08% |
Kas dari investasi | 267,71Â jt | 383,54% |
Kas dari pembiayaan | 26,47Â jt | -95,73% |
Perubahan kas bersih | 255,53Â jt | -40,42% |
Arus kas bebas | 146,12Â rb | 100,56% |
Tentang
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Didirikan
1 Jan 1998
Kantor pusat
Situs
Karyawan
939
